Skip to content

Multicenter registry on endovascular thrombectomy for posterior circulation occlusion

Multicenter registry on endovascular thrombectomy for posterior circulation occlusion

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000041117
Enrollment
Unknown
Registered
2020-12-18
Start date
2021-01-01
Completion date
Unknown
Last updated
2021-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Posterior Crculation IschemIc Stroke

Interventions

Case series:NA

Sponsors

The First Affiliated Hospital of China University of science and Technology (Anhui Provincial Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Patients over 18 years old; 2. Patients with preoperative Mrs score <= 2; 3. Patients with symptoms of vertebrobasilar artery occlusion and neurological deficit; 4. Patients with vertebral artery, basilar artery or posterior cerebral artery occlusion confirmed by CTA and / or MRA; 5. Those patients whose time from onset to femoral artery puncture is less than 24 hours.

Exclusion criteria

Exclusion criteria: 1. Patients with neuroimaging contraindications; 2. Patients with history of severe head injury or stroke in recent 3 months; 3. Patients suspected of subarachnoid hemorrhage; 4. In the past one week, there were patients who had artery puncture in the difficult compression hemostasis site; 5. Patients with previous intracranial hemorrhage; 6. Patients with intracranial tumors, arteriovenous malformations and aneurysms; 7. Patients with recent intracranial or intraspinal surgery; 8. Patients with active internal bleeding; 9. Patients with acute bleeding tendency, including platelet count less than 100 x 10^9 / L or other conditions; 10. Patients who received heparin treatment within 48 hours (APTT beyond the upper limit of normal range); 11. Patients with INR > 1.7 or PT > 15 seconds who have taken anticoagulant orally; 12. Patients with blood glucose less than 2.7 mmol /L.

Design outcomes

Primary

MeasureTime frame
90-day mRS score;

Secondary

MeasureTime frame
Inhospital Mortality;1year mRS score;Respiratory failure;Symptomatic hemorrhage;

Countries

China

Contacts

Public ContactHu Wei

The First Affiliated Hospital of China University of science and Technology (Anhui Provincial Hospital)

447596702@qq.com+86 15155510611

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 12, 2026